Ambrx's Series B Round

Ambrx raised a round of funding on April 15, 2005.

Ambrx is a clinical-stage biotechnology company focused on discovering and developing first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates. The company's proprietary…

Articles about Ambrx's Series B Round: